Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment
Fabio Bioletto(Department of Medical Sciences), Guillaume Assié(Centre National de la Recherche Scientifique), Fidéline Bonnet-Serrano(Centre National de la Recherche Scientifique), Bertrand Baussart(Centre National de la Recherche Scientifique), Nesrine Benanteur(Inserm), Anne Jouinot(Centre National de la Recherche Scientifique), Mirella Hage(Université de Versailles Saint-Quentin-en-Yvelines), Chiara Villa(Centre National de la Recherche Scientifique), Franck Letourneur(Inserm), Victor Gravrand, Yoann Martin(Centre National de la Recherche Scientifique), Maria Francesca Birtolo, Jean-François Emile(Hôpital Ambroise-Paré), Karine Perlemoine(Inserm), Marie-Laure Raffin-Sanson(Université de Versailles Saint-Quentin-en-Yvelines), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 1
Related Papers
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434